US Venture Partners X LP's Form 4 filing
eFFECTOR Therapeutics, Inc. (EFTR) · filed Nov 26, 2021
- Accession no.
- 0001062993-21-011704
- Filed
- Nov 26, 2021, 4:43 PM ET
- Trade date
- Nov 23-26, 2021
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $414.0K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| US Venture Partners X LPCIK 0001440514 | 10% Owner |
| Usvp X Affiliates LPCIK 0001453359 | 10% Owner |
| Tansey Casey MCIK 0001474322 | 10% Owner |
| Presidio Management Group X LLCCIK 0001602744 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 23, 2021 | Common Stock | SSaleDisposed | −14,418 | $7.40 | −$106,736.45 | 4,502,592 | Indirect | |
| Nov 23, 2021 | Common Stock | SSaleDisposed | −461 | $7.40 | −$3,413.24 | 144,047 | Indirect | |
| Nov 24, 2021 | Common Stock | SSaleDisposed | −35,388 | $7.36 | −$260,278.74 | 4,467,204 | Indirect | |
| Nov 24, 2021 | Common Stock | SSaleDisposed | −1,132 | $7.36 | −$8,325.86 | 142,915 | Indirect | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −4,870 | $7.01 | −$34,148.44 | 4,462,334 | Indirect | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −156 | $7.01 | −$1,093.25 | 142,759 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.